Regent Pacific Group Limited (HKG:0575)

Hong Kong · Delayed Price · Currency is HKD

0.9000

0.00 (0.00%)

At close: Mar 10, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biopharma	719.00K	291.00K	114.00K	3.25M	1.21M
Biopharma Growth	147.08%	155.26%	-96.50%	168.48%	639.02%
Total	719.00K	291.00K	114.00K	3.25M	1.21M
Total Growth	147.08%	155.26%	-96.50%	168.48%	67.87%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Europe	165.00K	243.00K	61.00K	54.00K	112.00K
Europe Growth	-32.10%	298.36%	12.96%	-51.79%	-55.91%
United States	18.00K	35.00K	29.00K	-	-
United States Growth	-48.57%	20.69%	-	-	-
Asia Pacific	536.00K	13.00K	24.00K	-	-
Asia Pacific Growth	4023.08%	-45.83%	-	-	-
China	-	-	-	3.20M	800.00K
China Growth	-	-	-	300.00%	-
Taiwan	-	-	-	-	300.00K
Total	719.00K	291.00K	114.00K	3.25M	1.21M
Total Growth	147.08%	155.26%	-96.50%	168.48%	67.87%

Source: S&P Global Market Intelligence.